Status:
COMPLETED
enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening
Lead Sponsor:
Centre Hospitalier Universitaire Vaudois
Conditions:
Arrhythmias, Cardiac
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research will investigate the PPG signal morphology related to physiological and non- physiological changes in arrhythmia-related heart rate as well as the performance of the PPG-based features p...
Detailed Description
The aim of the study is to acquire high quality PPG signals of various types of cardiac arrhythmias during diagnostic and therapeutic procedures, under controlled conditions (i.e., electrophysiology l...
Eligibility Criteria
Inclusion
- Age ≥ 18-year-old,
- Able to speak/read/understand French,
- Informed consent signed, and
- at least one of the following cardiac arrhythmias:
- sustained or non-sustained ventricular tachycardia,
- sustained or non-sustained atrial tachycardia
- atrial flutter,
- frequent atrial and/or ventricular ectopic beats,
- ventricular and/or atrial bigeminy,
- left bundle branch block,
- second- or third-degree atrioventricular block,
- atrioventricular reentrant tachycardia or atrioventricular node reentrant tachycardia,
- AF
Exclusion
- Patient is pregnant or breastfeeding,
- Refusal of participation by the patient
- Patient is less than 18 years old,
- Patient incapable of judgement or under tutelage, or
- Patient is already included in another human research project (ClinO/HRO) that may affect the objectives of this study.
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 21 2023
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT04884100
Start Date
September 15 2021
End Date
July 21 2023
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire Vaudois
Lausanne, Canton of Vaud, Switzerland, 1011